Details of the Drug Formulation (DFM)
General Information of DFM (ID: F13571) | |||||
---|---|---|---|---|---|
Name |
Methylphenidate 20 mg tablet
|
||||
Company |
Upstate Pharma
|
||||
Active Pharmaceutical Ingredient (API) | Methylphenidate | API Info click to show the detail info of this API | |||
Attention deficit hyperactivity disorder | ICD-11: 6A05 | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E0SJ4H | DIG Info | Beta-D-lactose | Diluent ... | ||
E07AGB | DIG Info | Cetyl alcohol | Coating agent ... | ||
E01UTP | DIG Info | Magnesium stearate | lubricant | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Magnesium stearate | |||||
Biological Activity | Protein expression downregulation (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
Cell line (CELL) | ||||||
DBT Name: Breast cancer FM3A cells (FM3A) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Cetyl alcohol | |||||
Biological Activity | EC50 = 1600 nM (estimated based on the structural similarity with CHEMBL28459 ) | [2] | ||||
Structural Similarity | Tanimoto coefficient = 0.861111111 | |||||
Tested Species | Mus musculus (Mouse) | |||||
Cellosaurus ID | CVCL_3869 | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.